Atlas Trials

Safety and Efficacy of RN1201 Injection as First-Line Treatment for Newly Diagnosed Multiple Myeloma

Clinical trial NCT07652138 · RECRUITING

Trial details

NCT number
NCT07652138
Sponsor
The First Affiliated Hospital of Soochow University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple MylomaNewly Diagnosed Multiple Myeloma (NDMM)
Start date
2025-07-30
Primary completion
2027-01-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.